<DOC>
	<DOCNO>NCT02946580</DOCNO>
	<brief_summary>Constipation know complication postoperative period spinal surgery , prescription pain medicine call opioids traditionally use high dos treatment surgery-related pain . The goal study determine effectiveness Movantik ( naloxegol ) —a FDA-approved drug use treat constipation cause opioids—in preventing constipation patient undergoing spinal fusion surgery MGH .</brief_summary>
	<brief_title>Naloxegol Prevention Constipation Postoperative Spinal Surgery Patients</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Naloxegol</mesh_term>
	<criteria>Male female patient age 18 75 year undergoing nonurgent , elective spinal fusion Massachusetts General Hospital admit neurosurgery floor operating room Patients take operating room another inpatient floor service ( already hospitalize prior surgery ) Patients evidence bowel obstruction Patients unable take oral medication mouth enteric feeding tube ( gastrostomy jejunostomy ) Patients document potential allergy adverse reaction Movantik ( naloxegol ) outpatient use Patients currently take Movantik ( naloxegol ) outpatient set Patients preoperative diagnosis irritable bowel syndrome ( IBS ) obtain via Rome III questionnaire screen Patients disruption bloodbrain barrier ( eg , multiple sclerosis , recent brain injury , Alzheimer 's disease , uncontrolled epilepsy ) Patients history cancer . Patients concomitantly use strong CYP3A4 inhibitor ( eg , clarithromycin , ketoconazole ) , strong CYP3A4 inducer opioid antagonist . Patients severe hepatic impairment . Patients previous history risk bowel perforation . Patients postop regional anesthetic technique employ like continuous epidural spinal . Patients local anesthetic place wound .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>